Data as of Oct 31
| -0.39 / -2.19%|
The 7 analysts offering 12-month price forecasts for BioDelivery Sciences International Inc have a median target of 21.00, with a high estimate of 29.00 and a low estimate of 19.00. The median estimate represents a +20.69% increase from the last price of 17.40.
The current consensus among 7 polled investment analysts is to Buy stock in BioDelivery Sciences International Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.